US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

13.45

-0.2100-1.54%

Volume:379.36K

Turnover:4.99M

Market Cap:420.85M

PE:-6.38

High:13.67

Open:13.59

Low:12.77

Close:13.66

52wk High:50.40

52wk Low:12.77

Shares:31.29M

Float Shares:15.69M

Volume Ratio:1.07

T/O Rate:2.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1087

EPS(LYR):-2.3387

ROE:-28.78%

ROA:-19.52%

PB:2.17

PE(LYR):-5.75

Loading ...

Overview Company News Filings

Dianthus Therapeutics Is Maintained at Outperform by Wedbush

Stoke Therapeutics Initiates Early-Stage Study for Genetic Vision Loss Treatment

MT Newswires Live

Outlook Therapeutics sumbits Type A meeting request to FDA

Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline

Stifel Nicolaus Initiates Coverage on BridgeBio Oncology Therapeutics With Buy Rating, $23 Price Target

MT Newswires Live

EXACT Therapeutics Holds Global Investor Call on Warrants Exercise Program

Amplia Therapeutics Opens Two Sites for Pancreatic Cancer Trial Enrollment; Shares Rise 4%

MT Newswires Live

Neural Therapeutics’ Hanf.com Stake Delivers 58% Revenue Surge and Positive Operating Income

Wedbush Cuts Price Target on Aprea Therapeutics to $7 From $11, Keeps Outperform Rating

MT Newswires Live

Defence Therapeutics Refines Accum ADC Strategy With New Scientific Advisory Board

Rapid Dose Therapeutics Enters Brazil’s Medical Cannabis Market With QuickStrip Launch

Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure

Sangamo Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Why Is Quince Therapeutics Stock Soaring Tuesday?

Agomab Therapeutics Closes $200 Million IPO

MT Newswires Live

Marker Therapeutics Sets Date for 2026 Annual Meeting

Lineage Cell Therapeutics Is Maintained at Buy by D. Boral Capital

Context Therapeutics to Participate in Upcoming Investor Conferences

Oruka Therapeutics to Participate in Multiple Upcoming Conferences

Vistagen Therapeutics Securities Litigation: When Clinical Optimism Meets Disclosure Duty

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LENZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":13.45,"timestamp":1770829628399,"preClose":13.66,"halted":0,"volume":379357,"delay":0,"changeRate":-0.015373352855051307,"floatShares":15692500,"shares":31289969,"eps":-2.10871,"marketStatus":"Trading","change":-0.21,"latestTime":"02-11 12:07:12 EST","open":13.59,"high":13.669,"low":12.77,"amount":4993697.3561309995,"amplitude":0.065813,"askPrice":13.49,"askSize":300,"bidPrice":13.42,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.10871,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":13.66,"preHourTrading":{"tag":"盘前","latestPrice":13.71,"preClose":13.66,"latestTime":"09:29 EST","volume":1566,"amount":21447.10602,"timestamp":1770820199999,"change":0.05,"changeRate":0.00366,"amplitude":0.057833},"postHourTrading":{"tag":"盘后","latestPrice":13.75,"preClose":13.66,"latestTime":"18:34 EST","volume":8851,"amount":121024.1,"timestamp":1770766448884,"change":0.09,"changeRate":0.006589,"amplitude":0.007321},"volumeRatio":1.066817,"impliedVol":1.3443,"impliedVolPercentile":0.9953},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":15692500,"roa":"-19.52%","roe":"-28.78%","lyrEps":-2.338654,"volumeRatio":1.066817,"shares":31289969,"dividePrice":0,"high":13.669,"amplitude":0.065813,"preClose":13.66,"low":12.77,"week52Low":12.77,"pbRate":"2.17","psRate":"24.05","week52High":50.4,"institutionHeld":0,"latestPrice":13.45,"committee":-0.5,"eps":-2.10871,"divideRate":0,"volume":379357,"delay":0,"ttmEps":-2.10871,"open":13.59,"prevYearClose":16,"prevWeekClose":14.22,"prevMonthClose":15.82,"prevQuarterClose":16,"fiveDayClose":14.62,"twentyDayClose":16.6,"sixtyDayClose":26.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-07","symbol":"LENZ","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1767762000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-05","symbol":"LENZ","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.59},{"market":"US","date":"2025-07-30","symbol":"LENZ","fiscalQuarterEnding":"2025/06","expectedEps":-0.58,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.4286,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5714,"analysts":7,"updateTime":1742187600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2026-02-09","current":-6.477894,"percent":0.855556,"low":-26.69966,"twenty":-17.191911,"median":-11.545952,"eighty":-8.358948,"high":-5.069183,"avg":-12.916349,"sd":5.106936,"marketCap":444943359},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543},{"date":"2025-07-25","current":-19.691695,"twenty":-16.100113,"median":-11.044571,"eighty":-7.492045,"marketCap":940081543},{"date":"2025-08-01","current":-16.20487,"twenty":-16.158905,"median":-11.077981,"eighty":-7.667213,"marketCap":849102797},{"date":"2025-08-08","current":-17.484059,"twenty":-16.20487,"median":-11.141188,"eighty":-7.667213,"marketCap":916129723},{"date":"2025-08-15","current":-22.268769,"twenty":-16.33076,"median":-11.193196,"eighty":-7.674511,"marketCap":1166838947},{"date":"2025-08-22","current":-21.691773,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"marketCap":1136605525},{"date":"2025-08-29","current":-20.793619,"twenty":-16.611183,"median":-11.233899,"eighty":-7.743848,"marketCap":1089544067},{"date":"2025-09-05","current":-21.729877,"twenty":-16.749673,"median":-11.252126,"eighty":-7.89274,"marketCap":1138602072},{"date":"2025-09-12","current":-22.214335,"twenty":-16.928962,"median":-11.290275,"eighty":-7.953319,"marketCap":1163986737},{"date":"2025-09-19","current":-22.693351,"twenty":-17.073997,"median":-11.339198,"eighty":-7.982513,"marketCap":1189086182},{"date":"2025-09-26","current":-21.789753,"twenty":-17.210778,"median":-11.419321,"eighty":-7.998378,"marketCap":1141739502},{"date":"2025-10-03","current":-26.302295,"twenty":-17.347559,"median":-11.473592,"eighty":-8.003646,"marketCap":1378187678},{"date":"2025-10-10","current":-25.175521,"twenty":-17.497557,"median":-11.534645,"eighty":-8.0071,"marketCap":1319146940},{"date":"2025-10-17","current":-22.018374,"twenty":-17.690689,"median":-11.749464,"eighty":-8.107241,"marketCap":1153718783},{"date":"2025-10-24","current":-16.034033,"twenty":-17.707197,"median":-11.991418,"eighty":-8.145558,"marketCap":840151237},{"date":"2025-10-31","current":-15.563946,"twenty":-17.690689,"median":-12.292165,"eighty":-8.168128,"marketCap":815519652},{"date":"2025-11-07","current":-10.439663,"twenty":-17.665927,"median":-12.292165,"eighty":-8.196087,"marketCap":614718687},{"date":"2025-11-14","current":-14.07658,"twenty":-17.595178,"median":-12.325665,"eighty":-8.25011,"marketCap":828871278},{"date":"2025-11-21","current":-14.730193,"twenty":-17.553908,"median":-12.761733,"eighty":-8.286974,"marketCap":867357940},{"date":"2025-11-28","current":-16.218091,"twenty":-17.524554,"median":-12.861347,"eighty":-8.308212,"marketCap":954969853},{"date":"2025-12-05","current":-14.825843,"twenty":-17.466248,"median":-13.119398,"eighty":-8.337771,"marketCap":872990135},{"date":"2025-12-12","current":-13.01911,"twenty":-17.42774,"median":-13.221067,"eighty":-8.354198,"marketCap":766604240},{"date":"2025-12-19","current":-9.070865,"twenty":-17.407695,"median":-13.037789,"eighty":-8.414622,"marketCap":534119770},{"date":"2025-12-26","current":-9.108063,"twenty":-17.390007,"median":-12.866196,"eighty":-8.500376,"marketCap":536310068},{"date":"2026-01-02","current":-8.502276,"twenty":-17.333409,"median":-12.777948,"eighty":-8.502276,"marketCap":500639504},{"date":"2026-01-09","current":-8.098418,"twenty":-17.315721,"median":-12.328345,"eighty":-8.502276,"marketCap":476859127},{"date":"2026-01-16","current":-9.639455,"twenty":-17.280347,"median":-12.249123,"eighty":-8.498134,"marketCap":567600037},{"date":"2026-01-23","current":-11.302713,"twenty":-17.228465,"median":-12.093174,"eighty":-8.501448,"marketCap":665537640},{"date":"2026-01-30","current":-9.448154,"twenty":-17.210778,"median":-11.871572,"eighty":-8.502276,"marketCap":556335648},{"date":"2026-02-06","current":-7.42355,"twenty":-17.195449,"median":-11.633633,"eighty":-8.39709,"marketCap":437120866},{"date":"2026-02-09","current":-7.556398,"twenty":-17.191911,"median":-11.545952,"eighty":-8.358948,"marketCap":444943359}],"updateTime":1770800123401},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610951696","title":"Dianthus Therapeutics Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2610951696","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610951696?lang=en_us&edition=fundamental","pubTime":"2026-02-11 23:39","pubTimestamp":1770824340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DNTH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2026 10:39 ET (15:39 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ"],"gpt_icon":0},{"id":"2610558199","title":"Stoke Therapeutics Initiates Early-Stage Study for Genetic Vision Loss Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2610558199","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610558199?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:12","pubTimestamp":1770819120,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics  said Wednesday that the first patient has received a dose in an early-stage trial of STK-002 for the treatment of Autosomal Dominant Optic Atrophy, an inherited vision loss condition.The open-label study's primary objective will be to evaluate the safety and tolerability of the investigational medicine in patients between the ages of 6 and 55, the company said.Researchers plan to monitor changes in visual function, eye structure, and quality of life as secondary goals of the clinical program, the company added.Stoke Therapeutics said the trial is currently enrolling participants with a confirmed genetic mutation linked to the condition in Germany and the UK, with additional European sites expected to activate in the coming months.The company also said the dose escalation for the initial four groups is expected to continue through this year and into early next year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SSI","LENZ","BK4139","BK4539","BK4007","STOK"],"gpt_icon":0},{"id":"2610680953","title":"Outlook Therapeutics sumbits Type A meeting request to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2610680953","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610680953?lang=en_us&edition=fundamental","pubTime":"2026-02-11 21:50","pubTimestamp":1770817819,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics (OTLK) submitted a Type A meeting request to the U.S. Food and Drug Administration following receipt of a Complete Response Le...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/outlook-therapeutics-sumbits-type-a-meeting-request-to-fda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/outlook-therapeutics-sumbits-type-a-meeting-request-to-fda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","LENZ","OTLK","BK4539"],"gpt_icon":0},{"id":"2610395694","title":"Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2610395694","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610395694?lang=en_us&edition=fundamental","pubTime":"2026-02-11 21:45","pubTimestamp":1770817500,"startTime":"0","endTime":"0","summary":"CEO Abizer Gaslightwala discusses the Company’s recent announcement around its ADC pipeline expansion and IP strategy Company also discusses its lead ADC program, AKTX-101, and its planned IND and CTA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/11/3236296/0/en/Akari-Therapeutics-Participates-in-Virtual-Investor-What-This-Means-Interview-Discussing-the-Company-s-Expanded-ADC-Pipeline.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK4539","ADC","LENZ","BK4007","BK4139","BK4080"],"gpt_icon":0},{"id":"2610932554","title":"Stifel Nicolaus Initiates Coverage on BridgeBio Oncology Therapeutics With Buy Rating, $23 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932554","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932554?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:18","pubTimestamp":1770812292,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics, Inc. (BBOT) has an average rating of Buy and mean price target of $25.13, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","LENZ"],"gpt_icon":0},{"id":"2610984560","title":"EXACT Therapeutics Holds Global Investor Call on Warrants Exercise Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2610984560","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610984560?lang=en_us&edition=fundamental","pubTime":"2026-02-11 16:05","pubTimestamp":1770797134,"startTime":"0","endTime":"0","summary":"EXACT Therapeutics AS ( ($DE:56F) ) has shared an update. EXACT Therapeutics AS will host a global investor call today in English to discuss matter...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exact-therapeutics-holds-global-investor-call-on-warrants-exercise-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exact-therapeutics-holds-global-investor-call-on-warrants-exercise-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AS","BK4539","LENZ","BK4202","BK4139","BK4007"],"gpt_icon":0},{"id":"2610260366","title":"Amplia Therapeutics Opens Two Sites for Pancreatic Cancer Trial Enrollment; Shares Rise 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610260366","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610260366?lang=en_us&edition=fundamental","pubTime":"2026-02-11 09:02","pubTimestamp":1770771722,"startTime":"0","endTime":"0","summary":"Amplia Therapeutics  said it opened two sites in the US, which will shortly start recruitment activities for its Amplicity trial, according to a Wednesday filing with the Australian bourse.The trial will evaluate the company's lead drug, narmafotinib, in advanced pancreatic cancer patients, the filing said.An additional three sites in the US will be initiated in the near future as recruitment continues, the filing added.Shares of the company rose past 4% in recent Wednesday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK4007","BK4139","LENZ","BK4539","ATX.AU"],"gpt_icon":0},{"id":"2610629328","title":"Neural Therapeutics’ Hanf.com Stake Delivers 58% Revenue Surge and Positive Operating Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2610629328","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610629328?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:35","pubTimestamp":1770734105,"startTime":"0","endTime":"0","summary":"The latest update is out from Neural Therapeutics Inc. ( ($TSE:NURL) ). Neural Therapeutics Inc. reported that its portfolio company CWE European H...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neural-therapeutics-hanf-com-stake-delivers-58-revenue-surge-and-positive-operating-income?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neural-therapeutics-hanf-com-stake-delivers-58-revenue-surge-and-positive-operating-income?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2610362583","title":"Wedbush Cuts Price Target on Aprea Therapeutics to $7 From $11, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2610362583","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610362583?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:43","pubTimestamp":1770730997,"startTime":"0","endTime":"0","summary":"Wedbush Cuts Price Target on Aprea Therapeutics to $7 From $11, Keeps Outperform Rating","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ"],"gpt_icon":0},{"id":"2610623727","title":"Defence Therapeutics Refines Accum ADC Strategy With New Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2610623727","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610623727?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:38","pubTimestamp":1770730720,"startTime":"0","endTime":"0","summary":"Defence Therapeutics ( ($TSE:DTC) ) has shared an announcement. Defence Therapeutics has convened a multidisciplinary Scientific Advisory Board to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-refines-accum-adc-strategy-with-new-scientific-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-refines-accum-adc-strategy-with-new-scientific-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4231","LENZ","BK4080","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2610623294","title":"Rapid Dose Therapeutics Enters Brazil’s Medical Cannabis Market With QuickStrip Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2610623294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610623294?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:36","pubTimestamp":1770730589,"startTime":"0","endTime":"0","summary":"Rapid Dose Therapeutics Corp ( ($TSE:DOSE) ) has issued an update. Rapid Dose Therapeutics has launched its co-branded QuickStrip medical cannabis ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rapid-dose-therapeutics-enters-brazils-medical-cannabis-market-with-quickstrip-launch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rapid-dose-therapeutics-enters-brazils-medical-cannabis-market-with-quickstrip-launch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MSOS","LENZ","MSOX","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2610063640","title":"Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2610063640","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610063640?lang=en_us&edition=fundamental","pubTime":"2026-02-10 20:58","pubTimestamp":1770728303,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics ( ($TSE:CRDL) ) just unveiled an update. Cardiol Therapeutics Inc., a late-stage life sciences company specializing in anti-in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cardiol-therapeutics-archer-phase-ii-myocarditis-data-published-in-esc-heart-failure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cardiol-therapeutics-archer-phase-ii-myocarditis-data-published-in-esc-heart-failure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2610642580","title":"Sangamo Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2610642580","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610642580?lang=en_us&edition=fundamental","pubTime":"2026-02-10 20:01","pubTimestamp":1770724860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGMO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 10, 2026 07:01 ET (12:01 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ"],"gpt_icon":0},{"id":"2610893641","title":"Why Is Quince Therapeutics Stock Soaring Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2610893641","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610893641?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:58","pubTimestamp":1770721080,"startTime":"0","endTime":"0","summary":"Quince Therapeutics, Inc.  stock is up during Tuesday’s premarket session as the company has engaged LifeSci Capital to serve as its exclusive financial advisor.The penny stock is trading higher on a robust session volume of 29.84 million versus the average volume of 2.92 million, according to Benzinga Pro data.Currently, Quince Therapeutics is trading 89.6% below its 20-day simple moving average  and 91.2% below its 100-day SMA, indicating significant weakness in the short to medium term. Over the past 12 months, shares have decreased by 90.91%, and they are positioned closer to their 52-week lows than highs, reflecting ongoing challenges for the company.The RSI is at 22.15, indicating that the stock is in oversold territory, which could suggest a potential for a rebound if buying interest increases. Meanwhile, the MACD is below its signal line, reinforcing the bearish pressure on the stock.The combination of oversold RSI and bearish MACD suggests mixed momentum, indicating that while","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/10/Close-Up-Computer-Display-With-Red-And-G.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/10/Close-Up-Computer-Display-With-Red-And-G.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50502899/why-is-quince-therapeutics-stock-soaring-tuesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50502899/why-is-quince-therapeutics-stock-soaring-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LENZ","BK4217","SMA","BK4139","BK4539","QNCX","BK4007"],"gpt_icon":0},{"id":"2610871664","title":"Agomab Therapeutics Closes $200 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2610871664","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610871664?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:28","pubTimestamp":1770676124,"startTime":"0","endTime":"0","summary":"Agomab Therapeutics  said late Monday it closed its initial public offering of 12.5 million American depository shares at a public offering price of $16 per ADS, raising about $200 million in gross proceeds before underwriting fees and expenses.The American depository shares started trading on the Nasdaq Global Select Market on Feb. 6.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGMB","LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2610691326","title":"Marker Therapeutics Sets Date for 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2610691326","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610691326?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:33","pubTimestamp":1770672829,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Marker Therapeutics ( ($MRKR) ). On February 9, 2026, Marker Therapeutics, Inc. announced that its Board of Dir...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marker-therapeutics-sets-date-for-2026-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marker-therapeutics-sets-date-for-2026-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","BK4007","LENZ"],"gpt_icon":0},{"id":"2610324658","title":"Lineage Cell Therapeutics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2610324658","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610324658?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:50","pubTimestamp":1770641400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LCTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 09, 2026 07:50 ET (12:50 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","LENZ"],"gpt_icon":0},{"id":"2610063011","title":"Context Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2610063011","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610063011?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:30","pubTimestamp":1770640200,"startTime":"0","endTime":"0","summary":"PHILADELPHIA, Feb.  09, 2026  (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/09/3234427/0/en/Context-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2610637278","title":"Oruka Therapeutics to Participate in Multiple Upcoming Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2610637278","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610637278?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:00","pubTimestamp":1770638400,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Feb.  09, 2026  (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new stand","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/09/3234400/0/en/Oruka-Therapeutics-to-Participate-in-Multiple-Upcoming-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2610634627","title":"Vistagen Therapeutics Securities Litigation: When Clinical Optimism Meets Disclosure Duty","url":"https://stock-news.laohu8.com/highlight/detail?id=2610634627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610634627?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:12","pubTimestamp":1770635542,"startTime":"0","endTime":"0","summary":"Legal Context: Obligations at the Intersection of Science and Securities Law Federal securities law imposes clear obligations on public companies: ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/vistagen-therapeutics-securities-litigation-when-clinical-optimism-meets-disclosure-duty?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/vistagen-therapeutics-securities-litigation-when-clinical-optimism-meets-disclosure-duty?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","US7Y.BOND","US10Y.BOND","BK4539","BK4139","US5Y.BOND","TMF","US2Y.BOND","US30Y.BOND","US12M.BOND","US3Y.BOND","TLT","TLTW","US6M.BOND","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}